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Abstract
Background: Previous studies in pregnancy have not focused in evaluating the effect of walking during pregnancy
and prevention of insomnia. Our general objective is to determine the effect of a walking program in preventing
the appearance of insomnia in the third trimester of pregnancy, increasing sleep quality and improving quality of
life throughout pregnancy.
Methods: Randomized Controlled trial in parallel in healthy sedentary pregnant women (n = 265), Walking_Preg
Project (WPP), from university hospital in Granada, Spain. At 12th gestational week (GW), they will be invited to
participate and randomly assigned to one of the three arms of study: the intervention group I1 (pedometer, goal of
11,000 steps/day), intervention group I2 (pedometer, no goal) and control (no pedometer). Duration of intervention:
13–32 GW. At 12th, 19th and 31st GW the average steps/day will be measured in groups I1 and I2. At 13th, 20th
and 32nd GW, Athens Insomnia Scale (AIS), Pittsburgh Sleep Quality Index (PSQI), Adherence to Mediterranean Diet
(AMD), physical activity (short IPAQ), quality of life (PSI), and consumption of toxic substances (caffeine, illegal drugs,
alcohol and tobacco) will be collected. Student t test or Mann-Whitney U will be used to compare 19th and 31st
GW mean of daily steps between I1 and I2 groups. To compare differences between groups in terms of frequency
of insomnia/quality of life for each trimester of pregnancy, Pearson’s Chi-square test or Fisher’s exact test will be
used. To determine differences in hours of sleep and quality of sleep throughout each trimester of pregnancy,
analysis of variance or Friedman test will be used. McNemar-Bowker test will be used to assess differences in life
quality in pre-post analyses in the 3 arms. We will use Stata 15 statistical software.
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Discussion: promoting walking in second half of pregnancy through use of pedometer and health pre-registration
of a goal to be achieved –'10,000–11,000 steps a day’– should prevent appearance of insomnia in third trimester,
will increase sleep quality and quality of life in pregnant women.
Trial registration: ClinicalTrials.gov Identifier: NCT03735381. Registered 8th November, 2018.
Keywords: Pedometer watch, Walking, Pregnancy, Insomnia
Background
The prevalence of insomnia at the beginning of preg-
nancy is around 40%, reaching over 60% in the third tri-
mester of pregnancy [1–4]. Insomnia is associated with
an increase of gestational diabetes mellitus (GDM), de-
pression in pregnancy and postpartum, arterial hyperten-
sion and preeclampsia as a result of the increase in
cytokine levels derived from sleep deprivation [5]. In-
somnia is also involved in unplanned caesarean sections,
prolonged labour, premature placental abruption, de-
layed intrauterine growth and prematurity [6].
It has been documented that practice of physical activ-
ity (PA) prevents the onset of insomnia in adults [7],
postmenopausal women [8] and pregnant women [9]. In
addition, the practice of regular PA (> 150 min/week)
also increases the quality of sleep in adults [10] and in
pregnancy [11]. However, only 20.3–30% of pregnant
women are active [12, 13]. In fact, pregnant women
spend more than 50% of their time in sedentary activities
[14]. To make an objective assessment of this, a woman
who counts less than 5000 steps/day on average could
be considered sedentary [15].
Walking is one of the recommended activities in the
guidelines of PA in pregnant women in Canada, Japan,
Norway and Spain and the most carried out during preg-
nancy [16, 17]. However, the number of steps/days counted
in the first trimester of pregnancy does not exceed 5000
steps [18], which is half of those recommended (10,000-11,
000) [19] and decreases as the gestation progresses [18].
Walking during pregnancy regulates, prevents or delays the
increase in blood pressure and cholesterol in healthy
women [20], decreases the prevalence of type 2 diabetes
mellitus [21] and improves glycaemic control of pregnant
women with GDM [22]. Moreover, improves cardiorespira-
tory capacity [23], decreases stress and anxiety and im-
proves sleep quality [24], increases quality of life [25] and
reduces weight gain during pregnancy [26].
The pedometer is a cost-effective tool that increases the
motivation to walk and increase the number of steps per
day by 2000 to 2500 [27] compared to those who do not
use it. The effectiveness of the pedometer is greater when
establishing a goal to achieve [28]. Different studies car-
ried out in pregnant women show that when all the partic-
ipants of the study use a pedometer, the establishment of
a goal of steps to be reached per day (10,000-11,000)
increases the mood and number of steps walked by the
person receiving such information [26, 29–33].
Some effects evaluated with the use of pedometers in
pregnant women are the increase of mood [34], the de-
crease in weight gain in obese pregnant women [26, 30],
the decrease in the incidence of preeclampsia [35] and
the reduction of back pain [36]. However, there are no
previous studies that analyse whether an intervention
aimed at promoting PA in pregnant women, based on
walking, helps to prevent insomnia that appears towards
the end of pregnancy and how it could have an impact
on the quality of life related to health and sleep quality
as pregnancy progresses.
Our hypothesis is that a program to promote walking
in the first half of pregnancy through the use of a ped-
ometer and through the health pre-registration of a goal
to be achieved –'10,000–11,000 steps a day’– prevents
the appearance of insomnia in the third trimester of
pregnancy, increases the quality of sleep and improves
the quality of life of pregnant women.
Aim
The main objective of this RCT is to determine the effect
of a program aimed at promoting physical activity in preg-
nant women based on walking during pregnancy in the
prevention of sleep hygiene disorders and improvement of
the quality of life in the third trimester of pregnancy.
Methods and design
The Walking_Preg Project, WPP study protocol follows
the SPIRIT guidelines and the SPIRIT flow diagram is
shown in Fig. 1. Walking_Preg Project (WPP) Consort
Flow Diagram is presented in Fig. 2. This is a Randomized
Controlled Trial with three groups in parallel: maximum
intervention group (I1): with pedometer, information and
objective of 10,000 steps/day to be achieved, minimum
intervention group (I2), with pedometer and information
but without goal of steps to be achieved, and control
group (C), without pedometer but with information on
physical activity recommendations and their benefits.
Arms and interventions
The three groups will receive information about the rec-
ommendation of physical activity during pregnancy, ac-
cording to ACOG guidelines [19].
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Arm 1
Intervention 1 (I1), maximum intervention: pedometer +
goal + reminds (maximum intervention women receive
information about the goal of steps/day to be reached:
10,000-11,000. They will receive messages on the mobile
phone remembering the goal to achieve and a notifica-
tion that the researching staff will proceed to collect the
average count of steps/day of the week prior to 20th and
32nd GW. Women will get recommendations on phys-
ical activity during pregnancy.
Arm 2
Intervention 2 (I2), minimum intervention: use of
pedometer watch from 12th to 32nd GW (10 weeks).
They will not receive goal information nor reminds to
collect information from the pedometer. Women will
be given recommendations on physical activity during
pregnancy.
Arm 3
No Intervention, control group: without pedometer.
Women will receive recommendations on physical activ-
ity during pregnancy.
Selection criteria for eligibility
Inclusion Criteria: 1) Pregnant women with a minimum
of 18 and maximum of 49 years of age; 2) Low medical
risk pregnancies that will be attending in the Unit of Ob-
stetrics and Gynecology, in a public third level Maternity
Hospital in Granada (Spain); 3) Sedentary women (< 5
days/week of moderate-vigorous physical activity at least
> 30min.; equivalent to < 7000 steps/day); 4) With
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Fig. 1 Walking_Preg Project (WPP) schedule of enrolment, interventions, and assessments
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mobile phone and e-mail; 5) Without intellectual deficits
or difficulty to understand the language.
Exclusion Criteria: 1) Chronic disease: diabetes, high-
pressure, cardiac or respiratory disease, liver or kidney
disease or mobility problems; 2) Women with relative or
absolute repose needed; 3) Active women (> 5 days/week
of moderate-vigorous physical activity at least > 30min.;
equivalent to > 7000 steps/day); 3) Insomnia at begin-
ning of pregnancy or having drugs for sleep problems.
The study sample will consist of women who, meeting
the inclusion criteria, agree to participate, upon request
for voluntary collaboration and signing of two documents:
1) Informed consent approved by the Provincial Ethics
Committee of Granada and 2) Pedometer loan certificate.
Location and data collection
The collection of the study sample began in June 2019
in the Obstetrics and Gynecology Department, where
the first uterine ultrasound is performed at 12th GW.
The Service Management Unit of Obstetrics and
Gynecology of the Maternal and Child Hospital –Virgen
de las Nieves University Hospital Complex, in Granada–
is the centre of care reference in the northern area of
Granada, a third level hospital that serves a reference
population of 439,035 corresponding to a sector of the
Granada Metropolitan District and the Basic Health
Zone of Alcalá la Real, Jaén. It has been a reference of
the Northeast Health Management Area of Granada.
Walking_Preg Project (WPP) schedule of enrolment,
interventions, and assessments is shown in Fig. 1. The
health staff will inform each woman of the study by re-
ferring them to an adjoining consultation enabled for a
member of the research team at the hospital. All women
who meet the inclusion criteria and sign the informed
consent and loan certificate will be invited to participate
in the study to reach target sample size. During the
Fig. 2 Walking_Preg Project (WPP) Consort Flow Diagram
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pregnancy, three interviews will be conducted by train-
ing staff (12th, 20th and 32nd GW), collecting the infor-
mation in an access database. The period of recruitment
of pregnant women will end in December 2020. We
have stopped the recruitment from March to August
2020, because of Covid-19. The period of follow-up of
women in the study will take place from the time of re-
cruitment of women (12th GW) until delivery.
Sample size
First, we have carried out the theoretical calculation of
the sample size for the definitive study (n = 265), based
on the following premises: 1) Three study arms: max-
imum intervention group, pedometer + goal + recall (I1):
minimum absolute reduction in the prevalence of low
compliance with recommendations that are statistically
significant to be detected, that it is 15% with respect to
I1; minimum intervention group, pedometer (I2): mini-
mum absolute reduction in the prevalence of low com-
pliance with recommendations that are statistically
significant to be detected, that is 30% with respect to C;
and control group (C), with an estimated prevalence of
low compliance with physical activity recommendations
of 50% [12, 13]. 2) Alpha error: 5%; 3) Power of the
study: 80%; 4) Comparison of I1 vs I2: from the previous
premises, 120 women would be needed in each arm;
Comparison of I1 vs C: from the previous premises, and
taking as reference the 120 women of the I1 arm re-
quired for the previous comparison, 25 women in the C
arm would be required.
A pilot of the previous design was carried out with 72
women not included in this study: 24 women in each
arm of the study, interviewed twice (12th and 20th GW),
during the months of February to May 2018. The re-
cruitment period was 3 months. To select a total of 265
women, 1 year and 7 months would be required (consid-
ering holiday periods and Covid-19). We estimate 20–
30% of losses in second and third interviews (due to
neonatal loss or abandonment of the study).
Randomization of participants and concealment
The Stata Ralloc program will generate a randomization
sequence by blocks of n = 9 and 3 arms per block (A, B
and C). In this way, each block of nine pregnant women
treated consecutively will be assigned, in a random
order, to the arms C (control), I1 (Intervention 1) and I2
(Intervention 2): C I1 I1 I1 I1 I2 I2 I2 I2, up to complete
the assignment of the 265 pregnant women. The se-
quence will be generated by the data analysts and kept
in the monitoring centre, remaining at all times hidden
to those clinicians responsible for the enrolment of preg-
nant women. Allocation sequence will be concealed until
women are assigned to interventions by the research
staff/interviewer. This way, the follow-up centre will be
contacted each time the interviewer has a pregnant
woman, so that they are informed of the arm to which
she will be assigned.
There will be concealment for the people in charge of
carrying out the evaluation and analysis of the data be-
cause they will manage the database without personal
women information or knowledge about the group inter-
vention, where women will be allocated. Due to the na-
ture of the study, neither the participants nor the
professionals who indicate the intervention can be
blinded. Participants will know they will be selected for
either a pedometer group or a non-pedometer group.
They will not know if the intervention is minimum (ped-
ometer only) or maximum (pedometer and a goal of 11,
000 steps/day).
Instruments
These are the main sources of information:
1) Structured interview that will be conducted in per-
son at 13th, 20th and 32nd GW. The duration of the in-
terviews will take approximately 35–40min, which
includes: the Athens Insomnia Scale (in English, AIS-8)
[37], the Pittsburgh Sleep Quality Questionnaire [38],
the Symptom Inventory in pregnancy [39, 40], short
IPAQ [41], Adherence to the Mediterranean Diet, with
Predimed questionnaire without wine [42]; 2) Record of
the average steps/day of weeks 19 and 31 of gestation
(information downloaded from the pedometer) and
quantification of average hours of sleep at 19th and 31st
GW (information downloaded from the Xiaomi Mi Band
2™ pedometer) (Fig. 1); 3) Clinical history: to collect the
variables related to birth (tertiary outcome variables) and
4) Subsequent telephone contact if necessary (correc-
tion of missing data).
Baseline variables collected
Variables collected only in the first interview (13th GW)
will be: Sociodemographic variables –age, number of
previous children, number of children under 3 years,
number of previous abortions, Spanish or foreign na-
tionality, stable couple, level of studies, occupation of
woman and partner (from these last two variables and
taking into account the highest value, social class was
calculated, with five categories in descending order I, II,
III, IV and V, according to the Spanish Society of Epi-
demiology [43]); Anthropometric variables: height and
pre-pregnancy weight.
Variables collected in all interviews
- Diagnosis of pathologies in pregnancy: gestational dia-
betes, high blood pressure induced by pregnancy or pre-
eclampsia and eclampsia.
- Drug use:
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1) Consumption of illegal drugs: use of opiates, co-
caine, cannabis and other drugs (specifying which) is re-
corded and if so, if the consumption is daily (number of
times), weekly, monthly or occasional (number of days
of consumption per week, per month or occasional and
number of times per day of consumption); 2) Consump-
tion of medication and supplements prescribed or not
by a physician, reason and duration; 3) Smoking habit:
1. Active daily smoker; 2. Occasional smoker; 3. Recent
former smoker (< 6 months); 4. Former smoker (> 6
months); 5. Never smoked [44]. Active smoker: average
number of cigarettes per day; age of onset of consump-
tion; Former smoker: How long ago did you stop smok-
ing? Years or months. Passive tobacco: does your partner
regularly smoke at home? If so: cigarettes/day; 4) Alco-
hol: number of drinks consumed daily, weekly, monthly
or occasionally (wine or cava, beer with alcohol or cider,
high-grade alcohol) [44] and 5) Caffeine consumption:
number of cups (or bottles) that are consumed daily,
weekly, monthly or occasionally of each of the following
beverages: coffee, decaffeinated coffee, tea, cola, energy
drinks and chocolates (milk or non-milk chocolate
tablet).
- Physical activity: short IPAQ questionnaire [41],
which includes the weekly frequency and minutes of
completion of intense, moderate and walking physical
activity. It allows the study sample to be classified into
three categories according to their activity per week: low
level or inactive (category I), moderate (category II) and
active (category III).
- Diet: Adherence to the Mediterranean Diet pattern
questionnaire, without wine [42]; 13-item questionnaire
(olive oil, vegetables, fruits, red meat, chicken, fish, le-
gumes, butter/margarine, carbonated drinks, industrial
pastries, nuts, stir-fry) that are part of the Mediterranean
diet. The higher the score obtained on the scale, the
greater the adherence to the Mediterranean diet and is
valued as acceptable adherence from 8 points.
Outcome measures
Primary outcome measures in the three arms:
1) Prevalence of insomnia in third trimester of preg-
nancy (time frame: 32nd GW) will be evaluated with
the Insomnia Athens Scale (IAS) [37], an eight-item
scale that assesses the quantity and quality of sleep
(first five items) and the diurnal repercussion of in-
somnia (daytime sleepiness, physical and mental func-
tioning and well-being during the day). Each of the
items scores from 0 to 3 (affectation of the item from
light to severe). The total score ranges from 0 to 24
points, considering insomnia from a score equal to or
greater than 6 points (Sensitivity = 93% and Specifi-
city = 85%) or equal to or greater than 7 points (Sen-
sitivity = 84% and Specificity = 90%).
2) Change in mean steps/day after intervention in
the arms using pedometer register (time frame: 19th and
32nd GW).
Secondary outcome measures in the three arms (time
frame: 12th, 19th and 32nd GW): Quality of sleep of
pregnant women measure with the Pittsburgh Question-
naire (PSQI) [38], it assesses the quality of the individ-
ual’s sleep during the previous month. It consists of 19
items grouped into seven components: quality, latency,
duration, efficiency and sleep disturbances, use of medi-
cation for sleep and diurnal dysfunction; each compo-
nent is scored from 0 to 3, according to a Likert scale in
which zero is the absence of the symptom and 3 is its
maximum presence. This will result in a score that
ranges from 0 to 21 points (the higher score, the worse
sleep quality): a PSQI score of > 5 indicates poor sleep
quality, with a diagnostic sensitivity of 89.6% and a spe-
cificity of 86.5%.
Other pre-specified outcome measures in the three
arms:
1. Quality of life of women through pregnancy (time
frame: 12th, 19th and 32nd GW), measure with the
Pregnancy Symptom Inventory (PSI) [39, 40]: 41-item
Likert scale developed from a group of experts and focus
groups. It registers the range of symptoms that appears
in the last month (Likert scale from 0 to 4: never, rarely,
sometimes, often) and its impact on quality of life, by af-
fecting the activities of daily life (scale Likert from 0 to
3: it does not limit me, it limits me a little, it limits me a
lot). It has been adapted to Spanish pregnant women
and is reliable (Kappa coefficient range = 0.6–0.9) [40]; 2.
Women weight gain in kilograms (time frame: 12th and
32nd GW), measured with the hospital scale; 3. Weight
of the new-born (time frame: delivery) collected from
the clinical history of the women; 4. Gestational week
at delivery (time frame: delivery) collected from the
clinical history of the women.
Data analysis
A descriptive analysis of the variables collected in the
study will be carried out. Measures of central tendency
and dispersion will be calculated for the numerical vari-
ables and absolute and relative frequencies for the quali-
tative ones. The normality of the variables will be
checked with the Kolmogorov-Smirnov test, in order to
determine whether parametric or non-parametric tests
will be carried out later. 95% confidence intervals (CI)
will be obtained for both means and proportions.
For the contrast of the hypothesis of equality between
the group of patients I1 and the group of patients I2, in
terms of the number of daily steps and for each GW
(19th and 31st), the Student t test will be used for inde-
pendent samples or Mann-Whitney U, as appropriate.
Subsequently, to assess whether there are differences
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between the groups with respect to the frequency of in-
somnia/quality of life for each trimester of pregnancy,
the Pearson’s Chi-square test or Fisher’s exact test will
be used when necessary.
On the other hand, to determine if differences are
found between the quantitative variables (hours of sleep,
quality of sleep) throughout the study period (first, sec-
ond and third trimester) among the participants, the
analysis of variance will be used for measurements re-
peated in the parametric case. In the case of having to
use a non-parametric test, the Friedman test will be
used. Subsequently, to assess the differences in the qual-
ity of life, for each of the groups, before starting the
walking program and after finishing it (pre-post), the
McNemar-Bowker test will be used.
For the contrast of the hypothesis of equality between
the three groups of patients, regarding the weight gained
during pregnancy (until 34 st GW), the weight of the
newborn and the gestational week, an analysis of the
variance or the test of Kruskall-Wallis will be used, as
appropriate. In case of statistical significance, multiple
comparisons will be obtained using the Student’s para-
metric test or the non-parametric Mann-Whitney U test
applying Bonferroni correction.
Finally, a bivariate mixed-effects logistic regression
model will be carried out to determine which variables
influence the greater frequency of insomnia, considering
the latter quantitatively. To delimit the extent to which
the associations that appear are explainable by the effect
of the rest of the variables included in the study, a multi-
variate mixed-effects logistic regression model will be
constructed. 95% confidence intervals (CI) will be ob-
tained. All contrasts will be bilateral and statistical sig-
nificance will be considered when the p value is ≤0.05.
The data analysis will be carried out by intention to
process and by protocol, using the Stata / SE v15.0 stat-
istical package.
Discussion
Currently, about 60% of pregnant women have insomnia
towards the end of pregnancy [1–4]. This study aims to
reduce the prevalence of insomnia in the third trimester
of pregnancy by 33% in the pedometer + goal group (max-
imum intervention) and, on the other hand, to reduce the
prevalence of insomnia by 16.6% in the pedometer-only
group (minimum intervention), compared to the control
group (usual advice without pedometer).
Women in the maximum intervention group are ex-
pected to have 33% less insomnia in the third trimester
of gestation compared to pregnant women in the control
group. Furthermore, in the intervention groups, sleep
quality will improve (Pittsburgh score < 5) [38], the fre-
quency of symptoms associated with pregnancy (asthe-
nia, anxiety, cramps) will decrease and the performance
of daily life activities (measured with the PSI question-
naire) will improve, compared to the control group.
The intervention requires health professional to ex-
plain the use of the pedometer and establish a thera-
peutic alliance with the pregnant woman to reach a goal.
The benefits are expected to be obtained during the pro-
ject and after its completion: 1) During the project, since
the participating women will increase their motivation
to walk, due to the use of the pedometer, and will bene-
fit from the inclusion of PA in their daily life, such as
decreased sedentary lifestyle and weight control in preg-
nancy. This will even encourage the practice of walking
from their closest social or family bond: 2) In the short
term, we will know if the expected potential change has
managed to reduce the prevalence of insomnia in the
third trimester of pregnancy, by at least 33%.
Direct and indirect costs are expected to be saved: 1)
Direct cost in pregnant women enrolled in the study
—decreasing sleep-related disorders, increasing quality
of sleep, quality of life and general well-being; 2) Indirect
costs for the Andalusian Health Service: reduction in the
number of visits in Primary Health Care derived from
the direct consequences of walking during pregnancy,
cost reduction in drugs related to the discomfort of
pregnancy. Depression, pregnancy weight control,
pregnancy-induced high blood pressure, or back pain
will be mitigated by promoting pregnancy walking.
This study will set support for the elaboration of
health promotion protocols in pregnant women through
walking. The findings of the beneficial effect derived
from the research can be incorporated into the usual ad-
vice of clinical practice. The results should be echoed
among health professionals involved in the care process
of pregnancy, childbirth and the puerperium, as well as
the scientific community.
Finally, this study will encourage walking in pregnancy.
In return, the participants will increase their general
well-being by improving their quality of life and sleep.
Abbreviations
WPP: Walking_Preg Project; GW: Gestational Weight; AIS: Athens Insomnia
Scale; PSQI: Pittsburgh Sleep Quality Index; AMD: Adherence to
Mediterranean Diet; IPAQ: International Physical Activity Questionnaire;
PSI: Pregnancy Symptom Inventory; GDM: Gestational Diabetes Mellitus;
PA: Physical Activity; RCT: Randomized Controlled Trial; ACOG: American
College of Obstetrics and Gynaecology
Acknowledgments
For their support of the study, we would like to thank the clinicians
collaborating with sample recruitment and those pregnant women taking
part on this Walking_Preg Project (WPP).
Authors’ contributions
CAP, ROR, RBR, JJJM, JLGV, made significant contributions in the study
protocol, identifying the research questions and designing the Randomized
Controlled Trial. The manuscript was drafted by CAP, ROR, RBR, SM, JMM,
while MNF and JLGV provided critical revision of the paper in terms of
important intellectual content. All authors (CAP, ROR, RBR, MNF, NAJ, IVZ, SM,
JMM, JJJM, JLGV) have read and approved the final submitted version.
Amezcua-Prieto et al. BMC Pregnancy and Childbirth          (2020) 20:521 Page 7 of 9
Funding
The WPP data study collection and publication expenses will be funded (PI-
0350-2018) by Fundación Pública Andaluza para la Investigación Biosanitaria
(FIBAO - IBS).
Availability of data and materials
No results or data are available to share.
Ethics approval and consent to participate
The study has been performed in accordance with the Declaration of
Helsinki [45]. Ethical approval for the planned study was obtained from
Research Ethics Committee,
in February 2019 (Peiba 1644-N-18). Compliance with the Organic Law 3/
2018, of December 5, on the Protection of Personal Data and guarantee of
digital rights and Regulation (EU) 2016/679 of the European Parliament and
of the Council of April 27, 2016, are guaranteed.
Written informed consent is requested from the participant women to: a) be
included in any of the study groups b) conduct personal interviews to
complete the questionnaires used; c) consultation of their clinical history; d)





The authors declare that they have no competing interests.
Author details
1Department of Preventive Medicine and Public Health, Faculty of Medicine,
University of Granada, Tower A, 8th Floor, Room 06, 18016 Granada, Spain.
2Consortium for Biomedical Research in Epidemiology & Public Health (CIBER
Epidemiología y Salud Pública-CIBERESP), 28029 Madrid, Spain. 3Instituto de
Investigación Biosanitaria ibs. GRANADA, Granada, Spain. 4Obstetrics and
Gynecology Service, Virgen de las Nieves University Hospital, 8014 Granada,
Spain. 5Department of Obstetrics and Gynecology, University of Granada,
18016 Granada, Spain.
Received: 23 July 2020 Accepted: 1 September 2020
References
1. Facco FL, Kramer J, Ho KH, Zee PC, Grobman WA. Sleep disturbances in
pregnancy. Obstet Gynecol. 2010;115(1):77–83.
2. Dorheim SK, Bjorvatn B, Eberhard-Gran M. Insomnia and depressive
symptoms in late pregnancy: a population-based study. Behav Sleep Med.
2012;10(3):152–66.
3. Sivertsen B, Hysing M, Dørheim SK, Eberhard-Gran M. Trajectories of
maternal sleep problems before and after childbirth: a longitudinal
population-based study. BMC Pregnancy Childbirth. 2015;15:129.
4. Fernández-Alonso AM, Trabalón-Pastor M, Chedraui P, Pérez-López FR.
Factors related to insomnia and sleepiness in the late third trimester of
pregnancy. Arch Gynecol Obstet. 2012;286(1):55–61.
5. Nodine PM, Matthews EE. Common sleep disorders: management strategies
and pregnancy outcomes. J Midwifery Womens Health. 2013;58(4):368–77.
6. Sharma SK, Nehra A, Sinha S, Soneja M, Sunesh K, Sreenivas V, et al. Sleep
disorders in pregnancy and their association with pregnancy outcomes: a
prospective observational study. Sleep Breath. 2016;20(1):87–93.
7. Tsunoda K, Kitano N, Kai Y, Uchida K, Kuchiki T, Okura T, Nagamatsu T.
Prospective study of physical activity and sleep in middle-aged and older
adults. Am J Prev Med. 2015;48(6):662–73.
8. Abedi P, Nikkhah P, Najar S. Effect of pedometer-based walking on
depression, anxiety and insomnia among postmenopausal women.
Climacteric. 2015;18(6):841–5.
9. Kolu P, Raitanen J, Luoto R. Physical activity and health-related quality of life
during pregnancy: a secondary analysis of a cluster-randomised trial. Matern
Child Health J. 2014;18(9):2098–105.
10. Kredlow MA, Capozzoli MC, Hearon BA, Calkins AW, Otto MW. The effects of
physical activity on sleep: a meta-analytic review. J Behav Med. 2015.
11. Loprinzi PD, Loprinzi KL, Cardinal BJ. The relationship between physical
activity and sleep among pregnant women. Ment Health Phys Act. 2012;5:
22–7.
12. Amezcua-Prieto C, Lardelli-Claret P, Olmedo-Requena R, Mozas-Moreno J,
Bueno-Cavanillas A, Jiménez-Moleón JJ. Compliance with leisure-time
physical activity recommendations in pregnant women. Acta Obstet
Gynecol Scand. 2011;90(3):245–52.
13. Broberg L, Ersbøll AS, Backhausen MG, Damm P, Tabor A, Hegaard HK.
Compliance with national recommendations for exercise during early
pregnancy in a Danish cohort. BMC Pregnancy Childbirth. 2015;15:317.
14. Fazzi C, Saunders DH, Linton K, Norman JE, Reynolds RM. Sedentary
behaviours during pregnancy: a systematic review. Int J Behav Nutr Phys
Act. 2017;14(1):32.
15. Jiang H, Qian X, Li M, Lynn H, Fan Y, Jiang H, et al. Can physical activity
reduce excessive gestational weight gain? Findings from a Chinese urban
pregnant women cohort study. Int J Behav Nutr Phys Act. 2012;9:12.
16. Doran FM, Buckley NA. Walking patterns in pregnancy. Aust J Prim Health.
2013;19(3):213–8.
17. Evenson KR, Barakat R, Brown WJ, Dargent-Molina P, Haruna M, Mikkelsen
EM, Mottola MF, Owe KM, Rousham EK, Yeo S. Guidelines for physical
activity during pregnancy: comparisons from around the world. Am J
Lifestyle Med. 2014;8(2):102–21.
18. Kim Y, Chung E. Descriptive epidemiology of objectively measured walking
among US pregnant women: National Health and nutrition examination
survey, 2005–2006. Prev Chronic Dis. 2015;12:150437.
19. Committee Opinion No ACOG. 650: physical activity and exercise during
pregnancy and the postpartum period. Obstet Gynecol. 2015;126(6):135–42.
20. OMS. Notas descriptivas, actividad física, datos y cifras 2016. http://www.
who.int/mediacentre/factsheets/fs385/es/. Accessed 20 Feb 2019.
21. Brekke HK, Bertz F, Rasmussen KM, Bosaeus I, Ellegard L, Winkvist A. Diet
and exercise interventions among overweight and obese lactating women:
randomized trial of effects on cardiovascular risk factors. PLoS One. 2014;
9(2):e88250.
22. Bain E, Crane M, Tieu J, Han S, Crowther CA, Middleton P. Diet and exercise
interventions for preventing gestational diabetes mellitus. Cochrane
Database Syst Rev. 2015;(4):Cd010443.
23. Ruchat SM, Davenport MH, Giroux I, Hillier M, Batada A, Sopper MM, et al.
Walking program of low or vigorous intensity during pregnancy confers an
aerobic benefit. Int J Sports Med. 2012;33(8):661–6.
24. Hollenbach D, Broker R, Herlehy S, Stuber K. Non-pharmacological
interventions for sleep quality and insomnia during pregnancy: a systematic
review. J Can Chiropr Assoc. 2013;57(3):260–70.
25. Elliott-Sale KJ, Barnett CT, Sale C. Exercise interventions for weight
management during pregnancy and up to 1 year postpartum among
normal weight, overweight and obese women: a systematic review and
meta-analysis. Br J Sports Med. 2015;49(20):1336–42.
26. Renault KM, Norgaard K, Nilas L, Carlsen EM, Cortes D, Pryds O, et al. The
Treatment of Obese Pregnant Women (TOP) study: a randomized controlled
trial of the effect of physical activity intervention assessed by pedometer
with or without dietary intervention in obese pregnant women. Am J
Obstet Gynecol. 2014;210(2):134.e1–9.
27. Kang M, Marshall SJ, Barreira TV, Lee JO. Effect of pedometer-based physical
activity interventions: a meta-analysis. Res Q Exerc Sport. 2009;80(3):648–55.
28. Moon DH, Yun J, McNamee J. The effects of goal variation on adult physical
activity behaviour. J Sports Sci. 2016;34(19):1816–21.
29. Maturi MS, Afshary P, Abedi P. Effect of physical activity intervention based
on a pedometer on physical activity level and anthropometric measures
after childbirth: a randomized controlled trial. BMC Pregnancy Childbirth.
2011;11(1):103.
30. Peacock AS, Bogossian FE, Wilkinson SA, Gibbons KS, Kim C, McIntyre HD. A
randomised controlled trial to delay or prevent type 2 diabetes after
gestational diabetes: walking for exercise and nutrition to prevent diabetes
for you. Int J Endocrinol. 2015;2015:423717.
31. Polgreen LA, Anthony C, Carr L, Simmering JE, Evans NJ, Foster ED, Segre
AM, Cremer JF, Polgreen PM. The effect of automated text messaging and
goal setting on pedometer adherence and physical activity in patients with
diabetes: A randomized controlled trial. PLoS One. 2018;13(5):e0195797.
32. Vetrovsky T, Cupka J, Dudek M, Kuthanova B, Vetrovska K, Capek V, Bunc V.
A pedometer-based walking intervention with and without email
counseling in general practice: a pilot randomized controlled trial. BMC
Public Health. 2018;18(1):635.
Amezcua-Prieto et al. BMC Pregnancy and Childbirth          (2020) 20:521 Page 8 of 9
33. Renault K, Nørgaard K, Secher NJ, Andreasen KR, Baldur-Felskov B, Nilas L.
Physical activity during pregnancy in normal-weight and obese women:
compliance using pedometer assessment. J Obstet Gynaecol. 2012;32(5):
430–3.
34. Taniguchi C, Sato C. Home-based walking during pregnancy affects mood
and birth outcomes among sedentary women: a randomized controlled
trial. Int J Nurs Pract. 2016;22(5):420–6.
35. Yeo S. Adherence to walking or stretching, and risk of preeclampsia in
sedentary pregnant women. Res Nurs Health. 2009;32(4):379–90.
36. Morino S, Kajiwara Y, Ishihara M, Nishiguchi S, Fukutani N, Tashiro Y, Yamada
M, Yamashita M, Aoyama T. The relationship between the daily step counts
and low back pain during pregnancy. Clin Exp Obstet Gynecol. 2016;43(2):
192–7.
37. Gomez-Benito J, Ruiz C, Guilera G. A Spanish version of the Athens
insomnia scale. Qual Life Res. 2011;20(6):931–7.
38. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh
sleep quality index: a new instrument for psychiatric practice and research.
Psychiatry Res. 1989;28(2):193–213.
39. Oviedo-Caro MA, Bueno-Antequera J, Munguía-Izquierdo D. Spanish version
of pregnancy symptoms inventory: transcultural adaptation and reliability. J
Matern Fetal Neonatal Med. 2016;17:1–8.
40. Foxcroft KF, Callaway LK, Byrne NM, Webster J. Development and validation
of a pregnancy symptoms inventory. BMC Pregnancy Childbirth. 2013;13:3.
41. Sanda B, Vistad I, Haakstad LAH, et al. Reliability and concurrent validity of
the International Physical Activity Questionnaire short form among
pregnant women. BMC Sports Sci Med Rehabil. 2017;9:7.
42. Gesteiro E, Rodríguez Bernal B, Bastida S, Sánchez-Muniz FJ. Maternal diets
with low healthy eating index or Mediterranean diet adherence scores are
associated with high cord-blood insulin levels and insulin resistance markers
at birth. Eur J Clin Nutr. 2012;66(9):1008–15.
43. Elisa C-R, Carlos Á-D, Antonia D-S. Utilización de las propuestas españolas
de medición de la clase social en salud (Use of Spanish proposals for
measuring social class in health sciences). Gac Sanit. 2012;26(6):566–9.
44. Encuesta Nacional de Salud Española (ENSE 2011-2012) https://www.mscbs.
gob.es/estadEstudios/estadisticas/encuestaNacional/encuesta2011.htm.
Accessed 20 Sep 2018.
45. General Assembly of the World Medical Association. World medical
association declaration of Helsinki: ethical principles for medical research
involving human subjects. J Am Coll Dent. 2014;81(3):14–8.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Amezcua-Prieto et al. BMC Pregnancy and Childbirth          (2020) 20:521 Page 9 of 9
